At a glance
ClinicalIndex Comparison RecordN/ACompleted· 22 enrolled
Drug / intervention
ViaLase Laserdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Prospective Single Center Clinical Study for Femtosecond Laser Glaucoma Surgery Using the ViaLase Laser
In Brief
A clinical study evaluating ViaLase Laser for Glaucoma and Glaucoma, Open-Angle. Completed, enrolled 22 participants across 1 site.
Detailed Summary
Prospective, single-center, multi-cohort clinical trial of ViaLase Laser for the reduction of IOP in patients with open angle glaucoma.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsGlaucoma, Glaucoma, Open-Angle
CountriesHungary
Collaborators--
Timeline
N/ACompletedFinished
202120222023202420252026
Enrollment StartSep 2020
First PostedJul 2021
Primary CompletionDec 2021
TodayJul 2026
First PostedJul 2, 2021
Enrollment StartSep 1, 2020
Primary CompletionDec 16, 2021
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 5 years ago
Interventions
ViaLase Laserdevice
ViaLase Laser System to create an aperture through the trabecular meshwork for the reduction of IOP in subjects with primary open-angle glaucoma